Dr. Kathleen Rousche serves as the Director of an Innovation Office within the Division of Extramural Research Activities, National Heart Lung and Blood Institute, National Institutes of Health. In this role, Kathleen oversees programs and activities designed to accelerate the translation of new discoveries into innovative biomedical products to prevent, diagnose, and treat heart, lung, and blood disorders. The Innovation Office coordinates the NHLBI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, and manages translational research initiatives directed at advancing new technologies from the university to the marketplace. The office is a central point-of-contact for information about the NHLBI’s small business funding opportunities, facilitates alliances between the federal and private sector stakeholders, and offers resources, entrepreneurial training, and advisory services to support biomedical innovators to more efficiently and effectively transition discoveries to benefit public health. Kathleen has a diverse background in translational biomedical research, program administration, teaching, and alliance management, and held positions in industry, academia, and medical communications prior to joining the NIH.